Antibacterial and antibiofilm effects of silver nanoparticles against the uropathogen Escherichia coli U12.

ABSTRACT: The drug-resistant bacterial strains' emergence increases day by day. This may be a result of biofilm presence, which protects bacteria from antimicrobial agents. Thus, new approaches must be used to control biofilm-related infections in healthcare settings. In such a study, biological silver nanoparticles were introduced in such a study as an anti-biofilm agent against multidrug-resistant E. coli U12 on urinary catheters. Seven different silver nanoparticles concentrations were tested for their antimicrobial activities. Also, anti-biofilm activities against E. coli U12 were tested. Using the dilution method, the silver nanoparticles concentration of 85 μg/ml was the MIC (Minimum Inhibitory Concentration) that had excellent biocompatibility and showed significant antibacteria

SUBMITTER: Selem E 

PROVIDER: S-EPMC9576564 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature